Skip to main content

Search

By Jeff Lagasse | 03:27 pm | November 10, 2025
The music is scientifically geared to promote relaxation and reduce anxiety, especially in workplace settings.
By Susan Morse | 11:23 am | November 05, 2025
Just as the FDA approves medical devices, there needs to be a pathway and a reviewing board to verify whether an AI model is credible, says Pluto CEO.
By Jeff Lagasse | 09:45 am | October 30, 2025
Evernorth saw adjusted revenues increase 15% compared to the same period in 2024.
By Susan Morse | 11:13 am | October 28, 2025
For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an average of 30%, Cigna says.
By Susan Morse | 11:03 am | October 21, 2025
Manufacturer EMD Serono is engaged by the Trump administration to bring the price of the medicine down by 84%.
By Jeff Lagasse | 10:48 am | October 21, 2025
Revenues have also increased 12.4% over that time, hitting $50.7 billion in the quarter.
By Susan Morse | 09:47 am | October 10, 2025
Thirty-four MA plans earned 5 stars in 2026 star ratings.
By Jeff Lagasse | 03:08 pm | September 30, 2025
The company now has relationships with Medicare, Medicaid and major commercial plans.
By Jeff Lagasse | 02:37 pm | September 23, 2025
Individuals with anxiety account for a disproportionate 27% of the total cost of care, data shows.
By Jeff Lagasse | 10:47 am | September 11, 2025
HonorHealth is promising high-quality care at the additional locations as well as “an expanded clinical knowledge base.”